These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 30822312)
1. A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma. Gao Z; Zhang D; Duan Y; Yan L; Fan Y; Fang Z; Liu Z PLoS One; 2019; 14(3):e0211491. PubMed ID: 30822312 [TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma. Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187 [TBL] [Abstract][Full Text] [Related]
3. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma. Luo Q; Cui M; Deng Q; Liu J Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192 [TBL] [Abstract][Full Text] [Related]
5. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis. Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194 [TBL] [Abstract][Full Text] [Related]
6. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis. Luo L; Zhou H; Su H BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer. Zhu X; Tan J; Liang Z; Zhou M Medicine (Baltimore); 2019 Jul; 98(30):e16672. PubMed ID: 31348324 [TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of a gene signature in clear cell renal cell carcinoma. Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359 [TBL] [Abstract][Full Text] [Related]
10. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma. Sun Z; Jing C; Xiao C; Li T; Wang Y Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247 [TBL] [Abstract][Full Text] [Related]
11. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer. Gong X; Siprashvili Z; Eminaga O; Shen Z; Sato Y; Kume H; Homma Y; Ogawa S; Khavari PA; Pollack JR; Brooks JD Oncotarget; 2017 Mar; 8(12):18657-18669. PubMed ID: 28423633 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma. Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930 [TBL] [Abstract][Full Text] [Related]
13. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma. Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822 [TBL] [Abstract][Full Text] [Related]
14. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma. Yang K; Lu XF; Luo PC; Zhang J Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146 [No Abstract] [Full Text] [Related]
15. Development of an Autophagy Score Signature for Predicting Overall Survival in Papillary Renal Cell Carcinoma. Gu X; Chen X; Zhu L; Song W; Wang A; Chu J; Wang T; Jiang P; Ge Y Dis Markers; 2020; 2020():8867019. PubMed ID: 33273989 [TBL] [Abstract][Full Text] [Related]
16. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients. Fei H; Chen S; Xu C BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375 [TBL] [Abstract][Full Text] [Related]
17. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues. Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
19. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. Chen L; Xiang Z; Chen X; Zhu X; Peng X Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma. Kang Z; Yang J J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]